Literature DB >> 8364135

Rolling review: gastro-oesophageal reflux disease.

S J Sontag1.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8364135     DOI： 10.1111/j.1365-2036.1993.tb00101.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  16 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

2.  Relationship between acid reflux episodes and gastroesophageal reflux symptoms is very inconstant.

Authors:  E Colas-Atger; B Bonaz; E Papillon; N Gueddah; A Rolachon; R Bost; J Fournet
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

3.  Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux.

Authors:  K C Trimble; S Douglas; A Pryde; R C Heading
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

Review 4.  Overlap of functional dyspepsia and GERD--diagnostic and treatment implications.

Authors:  Eamonn M M Quigley; Brian E Lacy
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-08       Impact factor: 46.802

Review 5.  Lansoprazole for maintenance of remission of erosive oesophagitis.

Authors:  James W Freston; Robert L Jackson; Bidan Huang; E David Ballard
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 6.  Ambulatory esophageal pH monitoring: technique, interpretations, and clinical indications.

Authors:  Radha K Dhiman; Vivek A Saraswat; Subhash R Naik
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

7.  Relationship of sliding hiatus hernia to gastroesophageal reflux disease: a possible role for Helicobacter pylori infection?

Authors:  Gianpiero Manes; Oreste Pieramico; Generoso Uomo; Sandro Mosca; Claudio de Nucci; Antonio Balzano
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

8.  Evidence for therapeutic equivalence of lansoprazole 30mg and esomeprazole 40mg in the treatment of erosive oesophagitis.

Authors:  Colin W Howden; E David Ballard; Weining Robieson
Journal:  Clin Drug Investig       Date:  2002       Impact factor: 2.859

Review 9.  Trends in the management of gastro-oesophageal reflux disease.

Authors:  J M Lee; C A O'Morain
Journal:  Postgrad Med J       Date:  1998-03       Impact factor: 2.401

Review 10.  Pharmacological management of gastro-oesophageal reflux disease.

Authors:  E C Klinkenberg-Knol; H P Festen; S G Meuwissen
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.